Alzheimer’s disease

A new mobile app to detect Alzheimer’s using speech data

The newly developed antibody 6H4 fragments (Fabs) specific to A? oligomers, encapsulated in the polymeric nanomicelles (PMs), were peripherally administrated to AD model mouse for 10 weeks. In mice that were administered anti-A?O 6H4 Fabs in the PMs, various toxic A? species (A? oligomers, A?42s, N3pE A?s, A?s with toxic conformer) and the presence of A? plaques with dense cores in the brain were significantly reduced. Additionally, suppression of the progression of pathological processes of AD was supported by the prevention of cognitive-behavioral decline in the spatial memory tests. CREDIT Department of Neurology and Neurological Science, TMDU

Crossing the blood–brain barrier to deliver antibodies to treat Alzheimer’s disease

Identifying early changes in Alzheimer’s disease before symptoms appear

Could a new vaccine help to halt the progression of Alzheimer’s disease?

The eyes may prove to be another valuable tool to diagnose Alzheimer’s

Targeting an early instigator of Alzheimer’s disease with new drugs

Could a non-invasive eye scan detect early Alzheimer’s Disease?

Alzheimer’s gamechanger: Starting early on a daily regimen of ibuprofen can prevent the onset of Alzheimer’s disease

Novel biomarkers of risk for future dementia found

Rendering mitochondria resistant to damage can halt diseases caused by amyloid toxicity, such as Alzheimer’s disease

Alzheimer’s disease symptoms may be alleviated by hyperbaric oxygen therapy

A new kind of antibody could provide a unified treatment approach for major neurological diseases

New technology could treat a wide range of conditions requiring tissue regeneration

Immune gene prevents Parkinson’s disease and dementia

Preventing Memory Loss Before Symptoms